China
Africa
Explore chapters and articles related to this topic
Biocomposites for Hyperthermia Applications
Published in Shakeel Ahmed, Saiqa Ikram, Suvardhan Kanchi, Krishna Bisetty, Biocomposites, 2018
Now well, there are a few reports where the MNPs have been coated with a biocompatible shell [124] or embedded in a polymer [125] to avoid aggregation and confer biocompatibility [126]. Recently, Soleymani et al. [127] have reported that polymer-coated La0.73Sr0.27MnO3 NPs can have potential applications in cancer hyperthermia therapy and magnetically activated drug delivery. But challenges in current magnetic drug-delivery systems include unacceptable coincidental heating of healthy tissue, control of the drug release time as well as the released amount, cytotoxicity, and biocompatibility. Therefore, more extensive work in this direction is required.
Recent Trends on Smart Bioresponsive Polymeric Materials
Published in Moayad N. Khalaf, Michael Olegovich Smirnov, Porteen Kannan, A. K. Haghi, Environmental Technology and Engineering Techniques, 2020
Kalpana N. Handore, Sumit B Sharma, Santosh Mishra, Vasant V. Chabukswar
Magnetic drug delivery systems possess advantages such as visualization of drug delivery vehicles, ability to control and guide the movement of drug carriers through magnetic fields and thermal heating which has been used to control drug release or produce tissue ablation. Magnetic drug carriers like magnetite, cobalt, ferrite, and carbonyl iron are mainly used and they are biocompatible, non-toxic, and non-immunogenic. Magnetic nanoparticles have also been encapsulated within liposomes. Polyelectrolyte-coated liposomes were highly stable as they showed no significant membrane disruption or leakage of encapsulated contents in the presence of detergent Triton TX-100.
Shock-tube study of the formation of iron, carbon, and iron–carbon binary nanoparticles: experiment and detailed kinetic simulations
Published in Combustion Science and Technology, 2019
P. A. Vlasov, G. L. Agafonov, D. I. Mikhailov, V. N. Smirnov, A. M. Tereza, I. V. Zhiltsova, A. E. Sychev, A. S. Shchukin, D. N. Khmelenin, A. N. Streletskii, A. B. Borunova, S. V. Stovbun
Magnetic nanoparticles have long been of technological and scientific interest, since they behave as small magnets having either ferromagnetic or superparamagnetic properties, which makes them attractive for a wide range of applications in electronic devices, information storage systems, catalysis, magnetic inks, etc. (Sun et al., 2000; Yi et al., 2006). Furthermore, magnetic nanoparticles have also attracted much attention in biomedicine as means of magnetic drug delivery, biosensing, magnetic hyperthermia, as well as in regenerative medicine and in magnetic resonance imaging as contrast enhancers (Chourpa et al., 2005; Jain et al., 2005; Miller et al., 2002).